In June, Harmony Biosciences’ Management Team will be attending two investor conferences in Miami. Learn more about our evolving pipeline and commitment to developing new treatment options for people living with rare neurological diseases who have unmet medical needs. More information: https://t.co/qXBRORktB3
#InvestorRelations
#IR
#Biosciences
#LifeSciences
It’s PWS Awareness Day!
PWS is a rare genetic neurological disorder with symptoms that include hyperphagia, excessive daytime sleepiness (EDS), and behavioral symptoms. More than half of people with PWS experience EDS, and there’s currently no FDA-approved treatment for this symptom in this patient population.
Take a few minutes to test your knowledge with our PWS quiz.
For more information about PWS, visit: https://t.co/MuUBBvNa5f
#PraderWilli
#PraderWilliSyndrome
#PWS
#RareDiseaseAwareness
#PatientAdvocacy
#EmpathyAndInnovation
Harmony Biosciences is heading to the 10th Annual Patients as Partners EU Conference, where advocates and pharma leaders explore how patient engagement can help drive smarter, faster, and more inclusive clinical research.
We’re proud to stand alongside patients and R&D teams to make trials more accessible, representative, and patient-focused.
#PatientsEU2026
#PatientEngagement
#ClinicalResearch
#RareDiseases
#Biosciences
#EmpathyandInnovation
We’re headed to #APA2026!
Harmony Biosciences will be attending the @APApsychiatric Annual Meeting, where clinicians, researchers, and mental health professionals gather to share new research and insights shaping the future of psychiatric care.
Looking forward to connecting with the community and engaging in discussions around neuroscience, sleep/wake disorders, and innovation.
Visit us in the exhibit hall if you’re there!
Learn more about our work: https://t.co/kcqUpAeGl7
#Psychiatry
#Neuroscience
#Biosciences
#SleepDisorder
#SleepDisorders
#EmpathyandInnovation
Earlier today, Harmony Biosciences announced the Company’s Q1 2026 financial results and confirmed 2026 net revenue guidance of over $1 billion. A profitable, self-funding biotech with an exceptionally strong commercial engine, Harmony Biosciences continues to deliver robust, sustained growth and drive value from our robust pipeline. Read more here: https://t.co/j1XRJbGNXh
#Earnings
#FinancialResults
#Biosciences
#Biotech
#LifeSciences
#Neurology
#Neurosciences
#InvestorRelations
#IR
This week, families and advocates will take their voices to Capitol Hill for the @PWSAUSA D.C. Fly-In.
We are proud to stand with the Prader-Willi syndrome (PWS) community, supporting their mission to raise awareness, drive action, and make their voices and stories heard.
Together, we can help shape a brighter future for people living with PWS.
Learn more about our commitment to PWS: https://t.co/vOsjJtveYb
#PraderWilliSyndrome
#RareDisease
#RareDiseases
#PatientAdvocacy
#Biosciences
#EmpathyandInnovation
Harmony Biosciences will be announcing the Company’s Q1 2026 financial results on May 7, 2026, during an earnings call. Learn more: https://t.co/E7x6Fg5iDL
#InvestorRelations#IR#Biosciences#LifeSciences
Earlier today, we announced that we will present encore open-label extension data from Harmony Biosciences’ rare #epilepsy pipeline at the 2026 American Academy of Neurology (AAN) Annual Meeting. The poster presentations will highlight data in an ongoing Phase 3 clinical study for the treatment of #Dravet syndrome. Learn more: https://t.co/NtaOcCVCzj
#AANAM
#DravetSyndrome
#Neurology
#Neuroscience
#RareNeurologicalDisorders
#Biosciences
#EmpathyAndInnovation
Our team is looking forward to attending the 2026 @AANmember Annual Meeting, one of the largest gatherings dedicated to advancing neurological science and patient care.
We hope to see you in the exhibit hall – come say “hello” if you’re there!
Learn more about our commitment to people living with rare neurological diseases who have unmet medical needs: https://t.co/wccTo6eMCE
#AANAM
#Neurology
#Neuroscience
#RareNeurologicalDisorders
#Biosciences
#EmpathyandInnovation
Earlier today, we announced the appointment of Glenn Reicin as Chief Financial Officer, effective today, supporting Harmony’s continued focus on strategic growth, financial strength, and long‑term value creation. This appointment reflects our continued focus on bringing innovative treatments to patients who have unmet medical needs and creating even greater value for our shareholders. Read more: https://t.co/QNSah2VIMT
#Biosciences
#LifeSciences
#Neurology
#Neurosciences
#Biotech
#InvestorRelations
#IR
Our team is looking forward to attending the 9th Congress of the International Pediatric Sleep Association (IPSA). This important gathering brings together clinicians, researchers, and experts dedicated to advancing pediatric sleep medicine.
We look forward to engaging with this community and contributing to conversations that help improve care for people living with sleep disorders.
Learn more about our work in Sleep/Wake disorders: https://t.co/nEZspcjpeB
If you’re attending #IPSA2026, come say “hello!”
#SleepMedicine
#PediatricSleep
#SleepResearch
#SleepDisorders
#Biosciences
#EmpathyandInnovation
Earlier today, we announced new leadership additions with the appointment of Peter Anastasiou as Chief Operating Officer of Harmony Biosciences and the appointment of Troy Ignelzi to our Board of Directors. These additions reflect our continued focus on supporting Harmony Biosciences’ next phase of growth and pursuing long‑term value creation for our shareholders, as we continue to advance our mission of bringing innovative treatments to patients with CNS disorders who have unmet medical needs. Read more: https://t.co/8iEtpuiXBy
#Biosciences
#LifeSciences
#Neurology
#Neurosciences
#Biotech
#InvestorRelations
#IR
Harmony Biosciences’ Management Team will participate in a fireside chat at the upcoming 25th Annual Needham Virtual Healthcare Conference. Learn more about our evolving pipeline and commitment to developing new treatment options for people living with rare neurological diseases who have unmet medical needs. More information: https://t.co/cdYTr9GcqV
#InvestorRelations
#IR
#Biosciences
#LifeSciences
Congratulations to our field sales team members who earned Harmony Biosciences’ annual Summit Club honor! This is an incredible achievement and you have set a standard for excellence.
#InHarmony#EmpathyandInnovation#GPTWcertified#GreatPlaceToWork#Biosciences#LifeSciences
#Biotech
#Pharmaceuticals
#RareDiseases
#RareDisease
#RareNeurologicalDisease
We’re incredibly proud to be at #SXSW sponsoring an exciting conversation with Axios Live that explores how entertainment can help the way we understand and experience healthcare and medical conditions, and why accurate portrayals in mass media matter more than ever.
Storytelling is powerful. The movies we watch, the TV shows we consume, and the characters we connect with often can have a profound influence on how society views health and wellness.
As part of this program, we are honored to spotlight the critical work of @project_sleep and their Hollywood & Sleep Initiative, championing more accurate representation of sleep health and people with narcolepsy on screen and beyond.
#SXSW26
#RareDisease
#RareDiseases
#rareneurologicaldisease
#rareneurologicaldiseases
#biosciences
#SleepWeek kicked off this past weekend with Suddenly Sleepy Saturday 2026 and we are joining the movement to shine a light on #narcolepsy.
This national awareness initiative by the @NarcolepsyNtwrk encourages the narcolepsy community everywhere to recognize this important day and advocate for those who live with narcolepsy every day.
Learn more about our commitment to sleep/wake disorders here: https://t.co/WjSIvA3J6O
#RareDisease
#Rarediseases
#Sleep
#Biosciences
#LifeSciences
#EmpathyAndInnovation
#InHarmony
On #InternationalWomensDay, we celebrate the women of Harmony Biosciences and embrace this year’s theme, #GiveToGain. By sharing our time, knowledge, and support, whether through mentorship, advocacy, or collaboration, we strengthen one another and advance our mission.
Each act of empathy and allyship uplifts our organization and moves us toward greater gender equality. Today and every day, we’re committed to fostering an inclusive environment where women can grow, lead, and succeed together.
Learn more about career opportunities at Harmony Biosciences and apply: https://t.co/hw4sLEvthc
#InHarmony
#GenderEquity
#EmpathyandInnovation
#GPTWcertified
#Biosciences
#Biotech
#LifeSciences
#Pharmaceuticals
#RareDiseases
#RareDisease
#RareNeurologicalDiseases